Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza. - Scott C; Kankanala J; Foster TL; Goldhill DH; Bao P; Simmons K; Pingen M; Bentham M; Atkins E; Loundras E; Elderfield R; Claridge JK; et al. (PLoS pathogens, 2020)